登革热血清状态快速诊断试验的系统综述与关键知情人访谈
本系统综述评估了登革热IgG快速诊断试验(RDT)在确定既往登革病毒感染中的性能,检索2000-2018年PubMed和EMBASE,纳入10项研究3137人。多数研究显示IgG RDT在继发感染或恢复期样本中灵敏度与特异度在80%-100%之间,但无研究直接报告用于确定血清状态的数据,需进一步研究在疫苗接种目标人群中的表现。
要点
- 当前登革热IgG RDT在继发感染中性能尚可,灵敏度与特异度多在80%-100%。
- 缺乏RDT用于确定登革热血清状态及与其他病毒交叉反应的数据。
- 需在疫苗接种目标人群中进一步评估RDT性能,或优化现有RDT。
核心结论
- 当前登革热IgG RDT在继发感染中与实验室检测相比性能尚可,但需在疫苗接种目标人群中进一步研究。
研究设计与样本
- 系统综述,检索PubMed和EMBASE数据库2000至2018年文献,纳入10项研究共3137人,多数使用血清样本,并用GRADE和QUADAS-2评价质量。
主要发现
- 多数研究显示登革热IgG检测在继发感染或近期感染恢复期样本中的灵敏度和特异度在80%至100%之间。
- 无研究直接报告用于确定登革热血清状态的数据,关于与其他病毒交叉反应的数据有限。
关键数值与推荐
- 多数研究报道登革热IgG RDT在继发感染或恢复期样本中灵敏度与特异度介于80%和100%之间。
临床怎么用
- 当前登革热IgG RDT可在一定程度上辅助判断既往登革病毒感染,但用于疫苗接种前筛查需谨慎,并应结合其他信息。
局限性
- 缺乏直接评估RDT确定登革热血清状态性能的研究,交叉反应数据有限,且研究多在继发感染或恢复期样本中进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Vaccination for dengue with the live attenuated tetravalent CYD-TDV vaccine (Dengvaxia®) is only recommended in individuals who have had prior dengue virus (DENV) infection. Rapid diagnostic tests (RDT) for past DENV infection would offer a convenient method for pre-vaccination screening at point-of-care. A systematic review was conducted to evaluate the performance of current dengue RDTs for determining dengue serostatus, using IgG antibodies against DENV as a marker of past infection. METHODS: PubMed and EMBASE databases were searched from 2000 to 2018 to identify studies evaluating dengue RDTs in individuals with known or possible previous DENV infection. Study quality was evaluated using GRADE and QUADAS-2 criteria. Semi-structured interviews were also performed with available dengue RDT manufacturers. RESULTS: The performance of four dengue IgG RDTs was determined in 3137 individuals across ten studies conducted in 13 countries, with serum used in most of the studies. No studies reported data for determining dengue serostatus, and limited data were available regarding cross-reactivity with other viruses. The majority of studies demonstrated sensitivities and specificities between 80% and 100% for dengue IgG detection in samples from secondary infection or convalescent time-points after recent infection. CONCLUSIONS: Although current dengue IgG RDTs have shown reasonable performance compared with laboratory-based tests in secondary infection, additional research is needed to determine how RDTs would perform in relevant populations targeted for vaccination. New RDTs or modifications to current RDTs are feasible and may optimize the performance of these tests for use in a pre-vaccination screening approach.
引用
- Luo R, Fongwen N, Kelly-Cirino C, et al. Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews. Clin Microbiol Infect. 2019. PMID: 30664935. doi:10.1016/j.cmi.2019.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。